Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 2/20 | 0.42 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.35 |
| ▸ | VHL | P40337 | 1/20 | 0.35 |
| ▸ | CTSA | P10619 | 1/20 | 0.35 |
| ▸ | SYK | P43405 | 1/20 | 0.35 |
| ▸ | CCR6 | P51684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL450834 | 0.85 | ALDH1A1 (0.42) | CHEK1EGLN2EGFRKDM4EALDH1A1 | |
| SCHEMBL12630708 | 0.84 | CHEK1 (0.51) | CHEK1DGAT1EGLN2EGFRJAK2 | |
| SCHEMBL14875772 | 0.82 | CDK8 (0.48) | CHEK1DGAT1EGLN2JAK2ALDH1A1 | |
| SCHEMBL9108886 | 0.82 | CHEK1 (0.42) | CHEK1DGAT1EGLN2EGFRGPR119 | |
| SCHEMBL17116597 | 0.79 | DGAT1 (0.48) | CHEK1DGAT1EGLN2PDE10AALDH1A1 | |
| SCHEMBL9024185 | 0.77 | CYP11B2 (0.53) | CHEK1DGAT1EGLN2 | |
| SCHEMBL31588411 | 0.77 | CHEK1 (0.63) | CHEK1DGAT1EGLN2KDM4EALDH1A1 | |
| SCHEMBL70602 | 0.77 | CHEK1 (0.63) | CHEK1DGAT1EGLN2KDM4EALDH1A1 | |
| SCHEMBL30112085 | 0.76 | CTSA (0.39) | CHEK1DGAT1EGLN2PDE10AGRIN2B | |
| SCHEMBL17502178 | 0.76 | ALDH1A1 (0.50) | CHEK1DGAT1EGLN2EGFRJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10954444-B2 | Liquid crystal compound and use thereof | LG CHEM, LTD. | 2021-03-23 | — | — | US | disclosed |
| US-20190016956-A1 | NOVEL LIQUID CRYSTAL COMPOUND AND USE THEREOF | LG CHEM, LTD. (KR) | 2019-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10954444-B2 | Liquid crystal compound and use thereof | CNOT9, SCLY, SFXN3 | CHEK1 703/4885DGAT1 3475/4885EGLN2 4566/4885 |
| US-20190016956-A1 | NOVEL LIQUID CRYSTAL COMPOUND AND USE THEREOF | CNOT9, SFXN3, TLK2 | CHEK1 631/4885DGAT1 3379/4885EGLN2 4635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.